{"count": 80, "results": [{"_id": "37904346", "pmid": 37904346, "pmcid": "PMC10615397", "title": "Causal association of metformin and osteoporosis: A 2-sample Mendelian randomization study", "journal": "Medicine (Baltimore)", "authors": ["Wei YK", "Chen PB", "Ju LL", "Deng GH"], "date": "2023-10-27T00:00:00Z", "doi": "10.1097/MD.0000000000035191", "meta_date_publication": "2023 Oct 27", "meta_volume": "102", "meta_issue": "43", "meta_pages": "e35191", "score": 50283.695, "text_hl": "Causal association of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@osteoporosis@@@: A 2-sample Mendelian randomization study", "citations": {"NLM": "Wei YK, Chen PB, Ju LL, Deng GH. Causal association of metformin and osteoporosis: A 2-sample Mendelian randomization study Medicine (Baltimore). 2023 Oct 27;102(43):e35191. PMID: 37904346", "BibTeX": "@article{37904346, title={Causal association of metformin and osteoporosis: A 2-sample Mendelian randomization study}, author={Wei YK and Chen PB and Ju LL and Deng GH}, journal={Medicine (Baltimore)}, volume={102}, number={43}, pages={e35191}}"}}, {"_id": "33062529", "pmid": 33062529, "pmcid": "PMC7550241", "title": "The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis", "journal": "Cureus", "authors": ["Aung M", "Amin S", "Gulraiz A", "Gandhi FR", "Pena Escobar JA", "Malik BH"], "date": "2020-09-12T00:00:00Z", "doi": "10.7759/cureus.10412", "meta_date_publication": "2020 Sep 12", "meta_volume": "12", "meta_issue": "9", "meta_pages": "e10412", "score": 50278.727, "text_hl": "The Future of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in the Prevention of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@-Related @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@Osteoporosis@@@", "citations": {"NLM": "Aung M, Amin S, Gulraiz A, Gandhi FR, Pena Escobar JA, Malik BH. The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis Cureus. 2020 Sep 12;12(9):e10412. PMID: 33062529", "BibTeX": "@article{33062529, title={The Future of Metformin in the Prevention of Diabetes-Related Osteoporosis}, author={Aung M and Amin S and Gulraiz A and Gandhi FR and Pena Escobar JA and Malik BH}, journal={Cureus}, volume={12}, number={9}, pages={e10412}}"}}, {"_id": "35869471", "pmid": 35869471, "pmcid": "PMC9306077", "title": "Metformin activates Wnt/beta-catenin for the treatment of diabetic osteoporosis", "journal": "BMC Endocr Disord", "authors": ["Huang X", "Li S", "Lu W", "Xiong L"], "date": "2022-07-22T00:00:00Z", "doi": "10.1186/s12902-022-01103-6", "meta_date_publication": "2022 Jul 22", "meta_volume": "22", "meta_issue": "1", "meta_pages": "189", "score": 50269.36, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ activates Wnt/@GENE_CTNNB1 @GENE_12387 @@@beta-catenin@@@ for the treatment of @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@diabetic osteoporosis@@@", "citations": {"NLM": "Huang X, Li S, Lu W, Xiong L. Metformin activates Wnt/beta-catenin for the treatment of diabetic osteoporosis BMC Endocr Disord. 2022 Jul 22;22(1):189. PMID: 35869471", "BibTeX": "@article{35869471, title={Metformin activates Wnt/beta-catenin for the treatment of diabetic osteoporosis}, author={Huang X and Li S and Lu W and Xiong L}, journal={BMC Endocr Disord}, volume={22}, number={1}, pages={189}}"}}, {"_id": "40261556", "pmid": 40261556, "title": "Senotherapeutic repurposing of metformin for age-related diseases and their signaling pathways.", "journal": "Mol Biol Rep", "authors": ["Turgut Ş", "Atasever E", "Cebe T", "Andican G", "Çakatay U"], "date": "2025-04-22T00:00:00Z", "doi": "10.1007/s11033-025-10524-0", "meta_date_publication": "2025 Apr 22", "meta_volume": "52", "meta_issue": "1", "meta_pages": "410", "score": 50268.223, "text_hl": "Senotherapeutic repurposing of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@age-related diseases@@@ and their signaling pathways.", "citations": {"NLM": "Turgut Ş, Atasever E, Cebe T, Andican G, Çakatay U. Senotherapeutic repurposing of metformin for age-related diseases and their signaling pathways. Mol Biol Rep. 2025 Apr 22;52(1):410. PMID: 40261556", "BibTeX": "@article{40261556, title={Senotherapeutic repurposing of metformin for age-related diseases and their signaling pathways.}, author={Turgut Ş and Atasever E and Cebe T and Andican G and Çakatay U}, journal={Mol Biol Rep}, volume={52}, number={1}, pages={410}}"}}, {"_id": "34523850", "pmid": 34523850, "title": "[Metformin and ageing: can treatment delay age-related diseases?]", "journal": "Ned Tijdschr Geneeskd", "authors": ["Verdurmen WPR"], "date": "2021-08-26T00:00:00Z", "meta_date_publication": "2021 Aug 26", "meta_volume": "165", "meta_issue": "", "meta_pages": "", "score": 50268.133, "text_hl": "[@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and ageing: can treatment delay @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@age-related diseases@@@?]", "citations": {"NLM": "Verdurmen WPR. [Metformin and ageing: can treatment delay age-related diseases?] Ned Tijdschr Geneeskd. 2021 Aug 26;165():. PMID: 34523850", "BibTeX": "@article{34523850, title={[Metformin and ageing: can treatment delay age-related diseases?]}, author={Verdurmen WPR}, journal={Ned Tijdschr Geneeskd}, volume={165}}"}}, {"_id": "35928902", "pmid": 35928902, "pmcid": "PMC9343600", "title": "Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice", "journal": "Front Endocrinol (Lausanne)", "authors": ["Nirwan N", "Vohora D"], "date": "2022-07-19T00:00:00Z", "doi": "10.3389/fendo.2022.944323", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "944323", "score": 50266.273, "text_hl": "The study provides the first evidence for the possible use of @CHEMICAL_Linagliptin @CHEMICAL_MESH:D000069476 @@@linagliptin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combination for managing @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@diabetic osteoporosis@@@.", "citations": {"NLM": "Nirwan N, Vohora D. Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice Front Endocrinol (Lausanne). 2022;13():944323. PMID: 35928902", "BibTeX": "@article{35928902, title={Linagliptin in Combination With Metformin Ameliorates Diabetic Osteoporosis Through Modulating BMP-2 and Sclerostin in the High-Fat Diet Fed C57BL/6 Mice}, author={Nirwan N and Vohora D}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={944323}}"}}, {"_id": "38536446", "pmid": 38536446, "title": "Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.", "journal": "Osteoporos Int", "authors": ["Cai Y", "Jun G", "Zhuang X"], "date": "2024-03-27T00:00:00Z", "doi": "10.1007/s00198-023-07013-0", "meta_date_publication": "2024 Mar 27", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50263.902, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ treatment reduces the incidence of @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@osteoporosis@@@: a two-sample Mendelian randomized study.", "citations": {"NLM": "Cai Y, Jun G, Zhuang X. Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study. Osteoporos Int. 2024 Mar 27;():. PMID: 38536446", "BibTeX": "@article{38536446, title={Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.}, author={Cai Y and Jun G and Zhuang X}, journal={Osteoporos Int}}"}}, {"_id": "35497918", "pmid": 35497918, "pmcid": "PMC9050299", "title": "Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus alpha-Glucosidase Inhibitors", "journal": "Evid Based Complement Alternat Med", "authors": ["Chen X", "Li X", "Kang S", "Duan W"], "date": "2022-04-21T00:00:00Z", "doi": "10.1155/2022/7707875", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "7707875", "score": 50263.0, "text_hl": "The role of cytokines in the pathogenesis of @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@osteoporosis@@@ can be observed by investigating the correlation between relevant factors and BMD after medication of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ plus @GENE_SI @GENE_6476 @@@alpha-glucosidase@@@ inhibitors. ", "citations": {"NLM": "Chen X, Li X, Kang S, Duan W. Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus alpha-Glucosidase Inhibitors Evid Based Complement Alternat Med. 2022;2022():7707875. PMID: 35497918", "BibTeX": "@article{35497918, title={Correlation of Serum IGF-1R, VEGF, and ET Levels with Bone Mineral Density in Type 2 Diabetic Mellitus Patients Treated with Metformin Plus alpha-Glucosidase Inhibitors}, author={Chen X and Li X and Kang S and Duan W}, journal={Evid Based Complement Alternat Med}, volume={2022}, pages={7707875}}"}}, {"_id": "35855344", "pmid": 35855344, "pmcid": "PMC9286921", "title": "Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease", "journal": "Aging Dis", "authors": ["Cheng FF", "Liu YL", "Du J", "Lin JT"], "date": "2022-07-11T00:00:00Z", "doi": "10.14336/AD.2021.1213", "meta_date_publication": "2022 Jul 11", "meta_volume": "13", "meta_issue": "4", "meta_pages": "970-986", "score": 50262.06, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@'s Mechanisms in Attenuating Hallmarks of @DISEASE_Aging_Premature @DISEASE_MESH:D019588 @@@Aging@@@ and @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@Age-Related Disease@@@", "citations": {"NLM": "Cheng FF, Liu YL, Du J, Lin JT. Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease Aging Dis. 2022 Jul 11;13(4):970-986. PMID: 35855344", "BibTeX": "@article{35855344, title={Metformin's Mechanisms in Attenuating Hallmarks of Aging and Age-Related Disease}, author={Cheng FF and Liu YL and Du J and Lin JT}, journal={Aging Dis}, volume={13}, number={4}, pages={970-986}}"}}, {"_id": "32905803", "pmid": 32905803, "title": "Is metformin a geroprotector? A peek into the current clinical and experimental data.", "journal": "Mech Ageing Dev", "authors": ["Zajda A", "Huttunen KM", "Sikora J", "Podsiedlik M", "Markowicz-Piasecka M"], "date": "2020-10-01T00:00:00Z", "doi": "10.1016/j.mad.2020.111350", "meta_date_publication": "2020 Oct", "meta_volume": "191", "meta_issue": "", "meta_pages": "111350", "score": 50260.875, "text_hl": "Additionally, a number of clinical trials prove positive effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on the prevalence of @<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@age-related diseases@@@ (@<m>DISEASE_Osteoporosis</m> @DISEASE_MESH:D010024 @@@ARD@@@), including @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular disease@@@ or @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@carcinoma@@@. ", "citations": {"NLM": "Zajda A, Huttunen KM, Sikora J, Podsiedlik M, Markowicz-Piasecka M. Is metformin a geroprotector? A peek into the current clinical and experimental data. Mech Ageing Dev. 2020 Oct;191():111350. PMID: 32905803", "BibTeX": "@article{32905803, title={Is metformin a geroprotector? A peek into the current clinical and experimental data.}, author={Zajda A and Huttunen KM and Sikora J and Podsiedlik M and Markowicz-Piasecka M}, journal={Mech Ageing Dev}, volume={191}, pages={111350}}"}}]}